Combined Effect of Low-Density Lipoprotein Cholesterol and Homocysteine on Major Adverse Cardiovascular Events in Coronary Heart Disease: A Retrospective Cohort Study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Residual cardiovascular risk remains substantial despite aggressive low-density lipoprotein cholesterol (LDL-C) lowering in coronary heart disease (CHD). Consequently, this elevated risk has spurred the search for non-lipid targets, such as homocysteine (HCY). However, the combined effect of HCY with LDL-C and the overall potential for combined risk stratification remain unclear. Methods: This retrospective cohort study included patients with CHD confirmed by coronary angiography or computed tomography angiography at the General Hospital of Ningxia Medical University between January 2019 and December 2021. Participants were stratified by baseline LDL-C levels (
Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Folate and B Vitamins Research
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Journal / source
- Reviews in Cardiovascular Medicine
- Volume
- 27
- Issue
- 3
- Pages
- 46290–46290
- Publication date
- 16 March 2026
- Language
- EN